From the New York Times. This article is notable for being about an epidemiologist with a perceived conflict of interest.
1. Why do you think a trial was justified?
2. Should scientists be prohibited from managing studies when they already favour one outcome?
And an episode of the Milk Street podcast. The bit in question comes very early in the episode. (And here's a longer article from The Atlantic, where the journalist interviewed on Milk Street gets deeper into the epidemiological weeds.)
1. What is the RR figure to get 22%? What is the PICO (population, intervention group, comparison group, outcome).
2. What is the hypothesised mechanism?
3. What would you do if you did a study and had an unexpected finding like this?